FeesSafety
Pluang+

Calamos Strategic Total Return Fund offers attractive income with recent 32% distribution boost amid tech sector volatility.

Market News
09 Nov 2026, 19:20 WIB
Seeking Alpha
View Source
Bullish
Calamos Strategic Total Return Fund offers attractive income with recent 32% distribution boost amid tech sector volatility.

The Calamos Strategic Total Return Fund (CSQ) remains appealing for income investors due to its attractive discount and recent strong equity performance. This year, CSQ has increased its distributions twice, totaling a 32% rise, highlighting its robust income potential. Despite recent volatility in the tech and AI sectors impacting the fund, the combination of discount pricing and income growth makes CSQ a compelling option for investors seeking steady returns. The fund is also supported by a community focused on income and arbitrage strategies in closed-end and exchange-traded funds.

The Calamos Strategic Total Return Fund (CSQ) is noted here with Pluang's market data for context. For readers following US stocks on Pluang, as of Nov 10, 2026 00:02 WIB, 119 of 150 priced US stocks rose while 31 fell. Notable gainers include MRVL at USD 154.92 with a 9.72% increase and a typical hold time of 46 days, HPE at USD 48.51 up 8.39% with a 35-day hold, and M at USD 24.98 rising 8.25% with a 60-day hold.

More News

Quadient reports 34.47M shares and 34.09M net voting rights as of October 30, 2026

Quadient reports 34.47M shares and 34.09M net voting rights as of October 30, 2026

Quadient S.A. disclosed its monthly update on shares and voting rights as of October 30, 2026. The company has a total of 34,468,912 ordinary shares and a net total of 34,091,172 voting rights. This information is relevant for shareholders and invest...

Company Fundamentals
Neutral
37 minutes ago
Quadient reports total shares and voting rights as of October 30, 2026.

Quadient reports total shares and voting rights as of October 30, 2026.

Quadient S.A. has disclosed its monthly update on the total number of ordinary shares and voting rights as of October 30, 2026. The company reports 34,468,912 total shares and theoretical voting rights, with 34,091,172 net voting rights. This disclos...

Company Fundamentals
Neutral
37 minutes ago
ADC Therapeutics beats Q3 2026 earnings estimates with rising ZYNLONTA sales and strong cash position.

ADC Therapeutics beats Q3 2026 earnings estimates with rising ZYNLONTA sales and strong cash position.

ADC Therapeutics reported a smaller adjusted loss per share of $0.16 in Q3 2026, beating the expected $0.21 loss, and revenue of $21.72 million, surpassing estimates of $18.7 million. The company’s main product, ZYNLONTA, continues to drive growth, w...

Company Fundamentals
Bullish
1 hour ago
Nokia transfers 847,057 treasury shares to employees under incentive programs.

Nokia transfers 847,057 treasury shares to employees under incentive programs.

Nokia has transferred 847,057 of its treasury shares to employees participating in its stock-based incentive programs, as per a board decision announced in October 2025. This transfer was done without compensation, fulfilling commitments under the in...

Company Fundamentals
Neutral
1 hour ago
Nokia transfers 847,057 shares to incentive plan participants, reducing its own holdings.

Nokia transfers 847,057 shares to incentive plan participants, reducing its own holdings.

Nokia Corporation transferred 847,057 of its own shares to participants of its equity-based incentive plans without any payment, following a board resolution. This transfer fulfills Nokia's commitments under these plans and reduces the company's own ...

Company Fundamentals
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App